Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate

The efficient targeting of drugs to tumor cell and subsequent rapid drug release remain primary challenges in the development of nanomedicines for cancer therapy. Here, we constructed a glucose transporter 1 (GLUT1)-targeting and tumor cell microenvironment-sensitive drug release Glucose–PEG–PAMAM-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Pengkai, Sun, Yi, Chen, Jianhua, Li, Hongpin, Zhu, Hongyu, Gao, Xing, Bi, Xinning, Zhang, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058575/
https://www.ncbi.nlm.nih.gov/pubmed/29282992
http://dx.doi.org/10.1080/10717544.2017.1419511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058575/
https://www.ncbi.nlm.nih.gov/pubmed/29282992
http://dx.doi.org/10.1080/10717544.2017.1419511

Ejemplares similares